ArticleTheranostics2015

EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.